Maria-Luisa Maccecchini - Jan 3, 2022 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Maria L. Maccecchini
Stock symbol
ANVS
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 06:42 PM
Previous filing
Jan 18, 2022
Next filing
Jan 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +83.4K $0.00 83.4K Jan 3, 2022 Common Stock 83.4K $19.78 Direct F1
transaction ANVS Stock Option (right to buy) Award $0 +19.9K $0.00 19.9K Jan 3, 2022 Common Stock 19.9K $19.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in eight consecutive quarterly installments of 10,425 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024.
F2 The stock option shall vest and become exercisable in two equal installments of 9,947 shares on March 31, 2022 and March 31, 2023.